IronBridge Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

IronBridge Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$263K	Sell	4,840 -2,070	-30%	-$114K	0.02%	186
2016 Q4	$404K	Sell	6,910 -1,360	-16%	-$74.4K	0.02%	162
2016 Q3	$446K	Hold	8,270	–	–	0.02%	160
2016 Q2	$608K	Hold	8,270	–	–	0.03%	158
2016 Q1	$528K	Sell	8,270 -7,410	-47%	-$467K	0.02%	157
2015 Q4	$1.08M	Buy	+15,680	New	+$1.04M	0.04%	156

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IronBridge Capital Management's BMY Position: Q1 2017 in Review

IronBridge Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 30% in Q1 2017, selling an estimated $114K and leaving 4,840 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #186.

IronBridge Capital Management first reported a position in BMY in Q4 2015 and has held it in 6 quarters since. The position peaked at $1.08M in Q4 2015. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

IronBridge Capital Management held 4,840 shares of Bristol-Myers Squibb worth $263K as of Q1 2017.
IronBridge Capital Management sold 2,070 Bristol-Myers Squibb shares in Q1 2017, an estimated $114K.
Bristol-Myers Squibb made up 0.02% of IronBridge Capital Management's portfolio in Q1 2017, its #186 holding.
IronBridge Capital Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 6 quarters since.
IronBridge Capital Management's Bristol-Myers Squibb position peaked at $1.08M in Q4 2015.
1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.